Published in Breast Cancer Res Treat on May 31, 2008
Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer. Br J Cancer (2010) 0.91
Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study. PLoS One (2013) 0.88
Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network. Eur J Cancer (2013) 0.88
Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast. J Natl Cancer Inst (2014) 0.81
Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study. Breast Cancer Res Treat (2016) 0.80
Assessment of breast cancer opportunistic screening by clinical-pathological indicators: a population-based study. Br J Cancer (2009) 0.78
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women. Breast Cancer Res Treat (2016) 0.77
Population-Based Effects of Mammography Screening in Bavaria on the Distribution of TNM-T Categories with Respect to Different Histological Subgroups. Breast Care (Basel) (2012) 0.75
[Diagnostics of microcalcifications from minimally invasive biopsies in mammography screening: results from the prevalence phase]. Pathologe (2009) 0.75
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 14.03
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst (2000) 4.15
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia (2011) 3.52
Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax (2004) 2.77
Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer (2008) 2.62
Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer (1991) 2.38
[Guideline 'Melanoma' (3rd revision)]. Ned Tijdschr Geneeskd (2005) 2.08
Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer. Ann Oncol (2012) 2.06
[The practice guideline: 'Treatment of tobacco dependence']. Ned Tijdschr Geneeskd (2005) 2.06
Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008. Br J Dermatol (2012) 2.03
[Surgery and referral for subsequent 131I therapy for patients with differentiated thyroid carcinoma in the south-east of the Netherlands, 1983-1996, compared to the consensus guidelines from 1987]. Ned Tijdschr Geneeskd (2002) 1.94
On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control (2007) 1.93
Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer (2005) 1.93
Determining the cause of death in randomized screening trial(s) for prostate cancer. BJU Int (2003) 1.90
Effect of abnormal screening mammogram on quality of life. Br J Surg (2010) 1.73
Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study. Eur J Cancer (2003) 1.70
Are patients with skin cancer at lower risk of developing colorectal or breast cancer? Am J Epidemiol (2008) 1.69
Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol (2003) 1.69
The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann Oncol (2010) 1.66
Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer (2002) 1.66
Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol (2005) 1.66
Implementation of a short-stay programme after breast cancer surgery. Br J Surg (2010) 1.54
The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery: a population-based study in Southeast Netherlands. Eur J Cancer (2001) 1.53
[Trends and variation in breast conserving surgery in the southeast and east of the Netherlands over the period 1990-2002]. Ned Tijdschr Geneeskd (2005) 1.50
Using loco-regional recurrence as an indicator of the quality of breast cancer treatment. Eur J Cancer (2004) 1.48
Variations in treatment policies and outcome for bladder cancer in the Netherlands. Eur J Surg Oncol (2010) 1.47
Prognosis for long-term survivors of cancer. Ann Oncol (2007) 1.47
[The correlation of age and comorbidity with therapy and survival in cancer patients in North-Brabant and North-Limburg, 1995-2001]. Ned Tijdschr Geneeskd (2005) 1.44
Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg (2005) 1.44
[Trends in the incidence and death from cancer from 1989-2003 in The Netherlands]. Ned Tijdschr Geneeskd (2006) 1.42
[Stump appendicitis after previous appendicectomy]. Ned Tijdschr Geneeskd (2008) 1.41
Presence of symptoms and timing of surgery do not affect the prognosis of patients with primary metastatic breast cancer. Eur J Surg Oncol (2011) 1.40
[A comparative study of the expenditures on health research in 7 western countries in 1997 places the Netherlands at the bottom of the list]. Ned Tijdschr Geneeskd (2002) 1.39
Bronchopleural fistula: the use of tissue glue. J Thorac Cardiovasc Surg (1992) 1.39
Cancer in children and adolescents in Europe: developments over 20 years and future challenges. Eur J Cancer (2006) 1.38
Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer (2003) 1.32
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg (2003) 1.31
Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer (2008) 1.29
Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer (2004) 1.29
Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis. Eur Urol (1999) 1.22
Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer (2004) 1.21
Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer (2001) 1.19
Improving outcome for patients with pancreatic cancer through centralization. Br J Surg (2011) 1.19
Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit Rev Oncol Hematol (2005) 1.19
Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT. Eur J Cancer (2011) 1.18
Clinical epidemiology of breast cancer in the elderly. Eur J Cancer (2007) 1.17
A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer (2006) 1.17
Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival. Breast Cancer Res Treat (2011) 1.16
A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br J Cancer (2010) 1.15
Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006. Ann Oncol (2010) 1.15
Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer (2006) 1.15
Higher prevalence of sexual dysfunction in colon and rectal cancer survivors compared with the normative population: a population-based study. Eur J Cancer (2012) 1.14
Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol (2005) 1.14
Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol (2009) 1.12
Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients. Eur J Surg Oncol (2008) 1.11
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer (2005) 1.10
Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews. Ann Hematol (2003) 1.10
Inter-observer variability in mammography screening and effect of type and number of readers on screening outcome. Br J Cancer (2009) 1.10
The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat (2007) 1.10
Breast cancer in the southeastern Netherlands, 1960-1989: trends in incidence and mortality. Eur J Cancer (1993) 1.09
Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer (2006) 1.09
Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. Eur J Cancer (2005) 1.08
Quality of life and health status in breast carcinoma. Eur J Surg Oncol (2004) 1.08
Does sunlight prevent cancer? A systematic review. Eur J Cancer (2006) 1.07
Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996. Eur J Cancer (2002) 1.06
Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg (2012) 1.06
Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer (2010) 1.06
Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer (2003) 1.04
Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer. Br J Surg (2012) 1.04
Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia (2012) 1.03
Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989. Br J Cancer (2010) 1.03
The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry. J Cancer Surviv (2013) 1.03